EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieKlinische Studie (Phase III)Open Access · CC BY 4.0

VYC-25L Is Safe and Effective for Enhancing the Chin and Jawline by Correcting Chin Retrusion in Chinese Adults

Yun Xie, Qingfeng Li, Hongyi Zhao, Zuoliang Qi, Jiaming Sun, Qian Tan, Dong Li, Zhiqi Hu, Ziyang Liu, Smita Chawla

Aesthetic Surgery Journal · 2025

DOI: 10.1093/asj/sjaf033 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Aesthetic Surgery Journal, 2025. Verfasst von Yun Xie und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermal Fillers, Cosmetic Techniques, Hyaluronic Acid, Lidocaine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Allergan Aesthetics, AbbVie company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individuals with chin retrusion may seek chin and lower jawline aesthetic enhancement.

Objectives

To evaluate VYC-25L (Juvéderm Volux XC; Allergan Aesthetics, an AbbVie company), a lidocaine-containing injectable hyaluronic acid dermal filler, for chin retrusion correction.

Methods

In this prospective, Phase 3, multicenter study (NCT04559984), Chinese adults with moderate-to-severe chin retrusion on the China (Allergan) Chin Retrusion Scale (CACRS) and glabella–subnasale–pogonion (G–Sn–Pog) angle <172.5° were randomized 2:1 to VYC-25L (treatment plus optional touch-up 4 weeks later) or no treatment (control). The primary endpoint was change from baseline (CFB) in G–Sn–Pog angle at Week 24. Secondary endpoints included CACRS response (≥1-point improvement), Global Aesthetic Improvement Scale (GAIS) response (improved/much improved), and FACE-Q Satisfaction with Chin score. Procedural pain was rated (0 = none to 10 = worst imaginable); injection-site responses (ISRs) were recorded daily for ≤28 days.

Results

The mean age of the patient (VYC-25L, n = 97; control, n = 51) was 31.2 years (range, 20-52 years). Mean CFB in G–Sn–Pog angle at Week 24 was 2.97° (VYC-25L) vs 0.09° (control; between-group difference, 3.08° [P < .0001]); improvement was maintained to Week 52. At Week 24, VYC-25L achieved higher responses vs control for CACRS (78.7% vs 18.8%, respectively; rate difference, 60.0%; P < .0001) and GAIS (92.6% vs 4.2%, respectively; rate difference, 88.4%; P < .0001); mean overall FACE-Q Satisfaction with Chin score was 70.4 vs 34.9, respectively. Mean (standard deviation) procedural pain was 2.6 (1.6); most ISRs were mild (41.8%) or moderate (50.0%) in severity.

Conclusions

In Chinese adults, VYC-25L safely and effectively corrected chin retrusion for at least 1 year. Level of Evidence: 2 (Therapeutic)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermal FillersCosmetic TechniquesHyaluronic AcidLidocaineHumansAdultFemaleMaleProspective StudiesChinMiddle AgedTreatment OutcomePatient SatisfactionChinaYoung AdultEstheticsProcedural PainAnesthetics, LocalEast Asian People

Substanzen

Dermal FillersHyaluronic AcidLidocaineAnesthetics, Local

Förderung

  • Allergan Aesthetics
  • AbbVie company

Zitieren

APA

Xie, Y., Li, Q., Zhao, H., Qi, Z., Sun, J., Tan, Q., Li, D., Hu, Z., Liu, Z., & Chawla, S. (2025). VYC-25L Is Safe and Effective for Enhancing the Chin and Jawline by Correcting Chin Retrusion in Chinese Adults. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjaf033

Vancouver

Xie Y, Li Q, Zhao H, Qi Z, Sun J, Tan Q, et al. VYC-25L Is Safe and Effective for Enhancing the Chin and Jawline by Correcting Chin Retrusion in Chinese Adults. Aesthetic Surgery Journal. 2025. doi:10.1093/asj/sjaf033

BibTeX
@article{Xie2025,
  author = {Xie, Yun and Li, Qingfeng and Zhao, Hongyi and Qi, Zuoliang and Sun, Jiaming and Tan, Qian and Li, Dong and Hu, Zhiqi and Liu, Ziyang and Chawla, Smita},
  title = {VYC-25L Is Safe and Effective for Enhancing the Chin and Jawline by Correcting Chin Retrusion in Chinese Adults},
  journal = {Aesthetic Surgery Journal},
  year = {2025},
  doi = {10.1093/asj/sjaf033}
}
Kostenlos starten →